Panlong Pharmaceutical: The company's products Panlong Seven Tablets and Tongguan Teng Tablets have been added to the National Essential Drug List.

Pandragon Pharmaceuticals announced that recently, the National Health Commission, the State Administration of Traditional Chinese Medicine, and the National Center for Disease Control and Prevention jointly released the "National List of Essential Medicines", which will be implemented from September 1, 2026. The company's products Pandragon Qipian and Tongguan Tengpian have been newly included in this list. Among them, Pandragon Qipian is exclusively selected for the treatment of rheumatic diseases, with broad market prospects. The inclusion of the company's core product Pandragon Qipian in the new version of the National List of Essential Medicines is conducive to continuously expanding the clinical application scope of the product, enriching clinical usage scenarios, further penetrating channels, deepening market coverage breadth and depth, continuously strengthening the clinical recognition and brand influence of the product, and playing a positive role in the company's long-term development.